Acadia Healthcare (ACHC)

• Market cap: $1.92B
• 1 day: -2.84%
• 5 days: -20.31%
• 1 month: -27.85%
• 3 months: -52.82%
• 6 months: -59.58%
• Year to date: -48.79%
• 1 year: -70.28%
• 5 years: -3.47%
• 10 years: -70.99%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Employees: 25,500

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

680% more call options, than puts

Call options by funds: $92.7M | Put options by funds: $11.9M

75% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 7 (+3) [Q4]

28% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 88

2.22% more ownership

Funds ownership: 105.8% [Q3] → 108.02% (+2.22%) [Q4]

1% less first-time investments, than exits

New positions opened: 75 | Existing positions closed: 76

2% less funds holding

Funds holding: 306 [Q3] → 301 (-5) [Q4]

36% less capital invested

Capital invested by funds: $6.22B [Q3] → $3.98B (-$2.25B) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $35 68% upside
• Avg. target: $43 108% upside
• High target: $65 211% upside

6 analyst ratings

• positive: 4 67%
• neutral: 2 33%
• negative: 0 0%

Guggenheim Jason Cassorla 31% 1-year accuracy 4 / 13 met price target	72% upside $36	Buy Initiated	9 Apr 2025
Mizuho Ann Hynes 67% 1-year accuracy 16 / 24 met price target	77% upside $37	Neutral Maintained	25 Mar 2025
RBC Capital Ben Hendrix 37% 1-year accuracy 24 / 65 met price target	106% upside $43	Outperform Maintained	3 Mar 2025
Keybanc Matthew Gillmor 36% 1-year accuracy 5 / 14 met price target	211% upside $65	Overweight Maintained	3 Mar 2025
Barclays Andrew Mok 46% 1-year accuracy 26 / 57 met price target	68% upside $35	Equal-Weight Downgraded	28 Feb 2025